Evidence map›Paper›PMID 28166678›Full record

ArticleAutoimmunity2017

Alterations in B cell development, CDR-H3 repertoire and dsDNA-binding antibody production among C57BL/6 ΔD-iD mice congenic for the lupus susceptibility loci sle1, sle2 or sle3.

Mohamed Khass, Robert L Schelonka, Cun Ren Liu, Ada Elgavish, Laurence Morel, Peter D Burrows, Harry W Schroeder

Open access · greenAbstract read
In one paragraph

Article in Autoimmunity, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Mohamed Khassa Department of Medicine , University of Alabama at Birmingham , Birmingham , AL , USA.
Robert L Schelonkac Department of Pediatrics , University of Alabama at Birmingham , Birmingham , AL , USA.
Cun Ren Liua Department of Medicine , University of Alabama at Birmingham , Birmingham , AL , USA.
Ada Elgavisha Department of Medicine , University of Alabama at Birmingham , Birmingham , AL , USA.
Laurence Moreld Department of Pathology , University of Florida , Gainesville , FL , USA , and.
Peter D Burrowse Department of Microbiology , University of Alabama at Birmingham , Birmingham , AL , USA.
Harry W Schroedera Department of Medicine , University of Alabama at Birmingham , Birmingham , AL , USA.
University of Alabama at Birmingham · USUniversity of Florida · US

Funding

Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI OLAF KUTSCH · 1988 to 2026
$84.1M
ROS Modulation of Innate and Adaptive Immunity in RAP30AR048311 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MOUNTZ, JOHN D · 2001 to 2017
$9.5M
Dental Academic Research Training Program (DART)T90DE022736 · NIDCR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Amjad Javed · 2012 to 2026
$6.7M
The role of Immunoglobulin CDRH3 in Autoimmune DiseaseR01AI048115 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SCHROEDER, HARRY WILLIAM · 2000 to 2010
$3.1M
HLA Region and KIR Genomics in Common Variable Immune DeficiencyU01AI090902 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SCHROEDER, HARRY WILLIAM · 2010 to 2014
$2.9M
The pre-BCR CDR-H3 sensing site and H chain selectionR21AI117703 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SCHROEDER, HARRY WILLIAM · 2015 to 2016
$404k
The Role of Immunoglobulin CDRH3 in Autoimmune DiseaseR56AI048115 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SCHROEDER, HARRY WILLIAM · 2012 to 2012
$366k
NIAID NIH HHS P30 AI027767NIAID NIH HHS R01 AI048115NIAID NIH HHS R21 AI117703NIAID NIH HHS R56 AI048115NIAID NIH HHS U01 AI090902NIAMS NIH HHS P30 AR048311NIDCR NIH HHS T90 DE022736
6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease that reflects a failure to block the production of self-reactive antibodies, especially those that bind double-stranded DNA (dsDNA). Backcrossing the lupus-prone NZM2410 genome onto C57BL/6 led to the identification of three genomic intervals, termed sle1, sle2 and sle3, which are associated with lupus susceptibility. We previously generated a C57BL/6 strain congenic for an immunoglobulin D

Indexed as

Quantitative Trait LociAllelesAmino Acid SequenceAnimalsAntibodies, AntinuclearAntibody FormationAutoantibodiesB-LymphocytesCell DifferentiationComplementarity Determining RegionsDisease Models, AnimalDisease SusceptibilityImmunoglobulin GImmunoglobulin MLupus Erythematosus, SystemicLymphocyte ActivationAntibodies, AntinuclearAutoantibodiesComplementarity Determining RegionsImmunoglobulin GImmunoglobulin MB-cell repertoireCDR-H3 and diversity gene segmentsDHSleSystemic lupus erythematosusthird complementary determining region heavy chain

Identifiers

PMID28166678
PMCPMC5551388
OpenAlexW2587272804

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.